Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2005
11/16/2005EP1196450B1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
11/16/2005EP1147085B1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors / tnf-alpha converting enzyme (tace) inhibitors
11/16/2005EP1114052B1 4-aminopyrrolopyrimidines as kinase inhibitors
11/16/2005EP0904099B1 Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005CN1697878A Novel peptides having cAMP producing activity
11/16/2005CN1697836A Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/16/2005CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/16/2005CN1697647A Liquor and method for restraining ache, inflammation and cartilage degradation
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227263C Peptide diagnostic and therapeutic agent for autoimmune diseases
11/16/2005CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
11/16/2005CN1227245C Food product and producing method
11/16/2005CN1227238C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
11/16/2005CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
11/16/2005CN1226999C Solubilized pharmaceutical composition for parenteral administration
11/16/2005CN1226982C Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system
11/15/2005US6965039 7-carboxy-flavone derivatives preparation method and therapeutic use
11/15/2005US6965027 Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis
11/15/2005US6964984 Preventing desensitization of receptors
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
11/15/2005US6964766 Peptides for use in immunotherapy of autoimmune diseases
11/10/2005WO2005105830A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105132A1 Methods for preventing or treating bone disorders
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005105125A1 Preventive or remedy for osteroporosis
11/10/2005WO2005105121A1 Use of platelets or platelet rich plasma (prp)
11/10/2005WO2005105118A1 Method for treating hypocalcemias, osteoporosis and fractures
11/10/2005WO2005002672A3 Sirt1 modulators for manipulating cells/organism lifespan/stress response
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005US20050250939 Process for the production of multiple cross-linked hyaluronic acid derivatives
11/10/2005US20050250936 Modified TGF-beta superfamily proteins
11/10/2005US20050250850 Amino acid composition promoting collagen synthesis
11/10/2005US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250771 Substituted indoles and their use as integrin antagonists
11/10/2005US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050249731 Methods of implating mesenchymal stem cells for tissue repair and formation
11/10/2005US20050249670 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
11/10/2005CA2607113A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005CA2564968A1 Modulation of cartilage homeostasis
11/10/2005CA2564368A1 Chemical compounds
11/10/2005CA2564169A1 Methods for preventing or treating bone disorders
11/10/2005CA2564085A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005CA2563830A1 Transdermal steroid formulation
11/10/2005CA2560165A1 Solid pharmaceutical form comprising an ltb4 antagonist
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593391A1 Remedy for degenerative intervertebral discs
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1592421A1 Heteroarylalkanoic acids as integrin receptor antagonists
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1423378B1 Aminopyrrole compounds as antiinflammatory agents
11/09/2005EP1411935A4 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1019389B1 Epothilone derivatives
11/09/2005EP0979226B1 Isoxazole derivatives
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694881A New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1226300C Ibuprofen sugar conjugated product and its preparation method and application
11/09/2005CN1226290C Ligands of nuclear receptor
11/09/2005CN1226265C Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1)-phenoxy- ethyl-pyrrolidine
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962940 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962928 such as 6-methoxy-2-(4-methoxyphenyl)-1-[4-(2-piperidin-1-yl-ethyoxy)-phenyl]-1,2,3,4-tetrahydroquinoline
1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 820